The team expects that the method can make it possible to mass produce the cells, known for their effectiveness in suppressing ...
Ninety percent of paralyzed patients regained strength or function of their upper limbs after receiving an experimental ...
TOKYO -- A Japanese startup is poised to become the first in the world to seek government approval for a therapy derived from ...
A Blue Cross Blue Shield study of one decade worth of claims for Saxenda and Wegovy found 58% of patients quit the ...